GIA
TEVA icon

Guyasuta Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Guyasuta Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-10,042
Closed -$462K – 216
2016
Q3 		$462K Sell
10,042
-3,900
-28% -$203K 0.06% 140
2016
Q2 		$700K Buy
13,942
+2,500
+22% +$133K 0.09% 110
2016
Q1 		$612K Buy
11,442
+5,975
+109% +$351K 0.09% 118
2015
Q4 		$358K Buy
+5,467
New +$338K 0.05% 152

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Guyasuta Investment Advisors's TEVA Position: Q4 2016 in Review

Guyasuta Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 10,042 shares — an estimated $462K sold.

Guyasuta Investment Advisors first reported a position in TEVA in Q4 2015 and held it in 4 quarters. The position peaked at $700K in Q2 2016. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Guyasuta Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Guyasuta Investment Advisors sold 10,042 Teva Pharmaceuticals shares in Q4 2016, an estimated $462K.
  • Guyasuta Investment Advisors first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Guyasuta Investment Advisors's Teva Pharmaceuticals position peaked at $700K in Q2 2016.
  • 737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Guyasuta Investment Advisors's 13F filing for Q4 2016, filed 7 Feb 2017.